Examine how branded and biosimilar companies build, litigate, and defend formulation and delivery patents as core composition claims expire and these assets become the last line of exclusivity.
Speaker(s):
Lachlan Campbell-Verduyn
Partner
Patterson Belknap
Andrew Cohen
Partner
Patterson Belknap
Agenda Track No.:
Track 3
Session Type:
Break / Networking
Force Inline Description:
0